C

Compass Pathways

Develops psilocybin-based therapies for TRD

Vendor Relationship Manager

Supply Chain ManagementPosted on Nov 10
Full-timeRemote in UKNo salary listedRemote

About the Job

Requirements

  • A BSc or equivalent in a Life Sciences or Engineering discipline, with 1–2 years in a similar role.
  • Experience project managing manufacturing or packaging initiatives in the current Good Manufacturing Practice industry.
  • Broad knowledge of biotechnology or pharmaceutical manufacturing processes, with scientific analysis and interpretation skills and the ability to solve problems creatively.
  • Experience handling scheduled controlled drugs, including specialized vault requirements, high-security logistics, and quota management.
  • Understanding of Medicines and Healthcare products Regulatory Agency, U.S. Food and Drug Administration current Good Manufacturing Practices, and Drug Enforcement Administration regulations governing highly restricted pharmaceutical components.
  • Ability to translate technical chemistry, manufacturing, and controls complexities into actionable vendor management, supporting supply-chain and technical teams with planning and logistics requirements.
  • Competence switching between clinical-trial troubleshooting and commercial-launch process control.

Responsibilities

  • Manage supply-chain vendors end to end to ensure availability of outsourced drug substances, drug products, or finished goods.
  • Identify critical issues and risks, develop action plans, and keep stakeholders informed of impacts on supply.
  • Collect and maintain information about entities, including contractual terms, financial expenses, and strategic road maps.
  • Ensure accountability for vendor performance.
  • Set up business review meetings to report on performance, action plans, and recommendations.
  • Supervise the collection and review of supply-chain, finance, quality, and other key performance indicators.
  • Coordinate vendor schedules to secure timely, Good Practice-compliant manufacturing and distribution of Schedule I materials for active global Phase 2/3 clinical protocols.
  • Manage supply-chain flexibility for clinical needs while supporting process-scale frameworks with commercial vendors.
  • Collaborate with Regulatory Affairs and supply chain to meet timelines for applications and procurement of applicable manufacturing and distribution licenses.
  • Oversee vendor management to ensure manufacturing and supply-site quotas are delivered on time and fulfilled.
  • Serve as the primary relationship owner for contract development and manufacturing organizations and contract manufacturing organizations, driving routine external and internal meetings.
  • Partner with supply-chain and legal leaders to negotiate Master Services Agreements, Statements of Work, and commercial supply agreements with structured service-level agreements.
  • Oversee vendor risk assessments and formulate proactive dual-sourcing strategies to mitigate high-barrier entry constraints in scheduled-product manufacturing.
  • Manage project resources to resolve supply issues and support life-cycle management in coordination with stakeholders.
  • Review and manage the Chemistry, Manufacturing, and Controls manufacturing financial budget for clinical and commercial manufacturing.

Desired Qualifications

  • A BSc in a Life Sciences discipline, or relevant experience, with 2–3 years in a similar role.

About the Company

Compass Pathways

Develops psilocybin-based therapies for TRD

COMPASS Pathways develops psilocybin-based therapies for mental health, focusing on treating treatment-resistant depression (TRD). Its lead drug candidate, COMP360, is a high-purity psilocybin formulation given alongside psychological support from trained therapists. The treatment is delivered through a global Phase 3 program, aiming to establish a regulatory-approved therapy. Compared with other players, COMPASS emphasizes a standardized therapeutic model that pairs a pharmaceutical compound with guided psychotherapy and has the largest psilocybin Phase 3 program to date, supported by Breakthrough Therapy designation from the FDA. The company originated from a nonprofit idea, transformed into a for-profit entity to fund extensive trials, and is pursuing regulatory approval and eventual commercialization through licensing and partnerships. Its goal is to bring approved, evidence-based psilocybin treatments to patients with TRD and scale access through a commercial pathway.

Company size
201-500
Company stage
IPO
Headquarters
London, United Kingdom
Founded
2016

Recently Posted Jobs

Explore more opportunities at Compass Pathways

See more jobs